{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:36:44Z","timestamp":1794530204785,"version":"4.9.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":1642,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1469-0691.2010.03214.x","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T11:01:54Z","timestamp":1299495714000},"page":"555-562","source":"Crossref","is-referenced-by-count":320,"title":["Management of multidrug-resistant enterococcal infections"],"prefix":"10.1016","volume":"16","author":[{"given":"C.A.","family":"Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2010.03214.x_bib1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial\u2010resistant pathogens associated with healthcare\u2010associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2010.03214.x_bib2","first-page":"ii75","article-title":"Non\u2010susceptibility trends among enterococci and non\u2010pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001\u201306","volume":"62","author":"Brown","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib3","first-page":"13","article-title":"Emergence and spread of vancomycin resistance among enterococci in Europe","volume":"20","author":"Werner","year":"2008","journal-title":"Euro Surveill"},{"issue":"suppl 3","key":"10.1111\/j.1469-0691.2010.03214.x_bib4","first-page":"iii13","article-title":"Clinical impact of vancomycin\u2010resistant enterococci","volume":"51","author":"Patel","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib5","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1128\/AAC.36.11.2355","article-title":"Beta\u2010lactamase\u2010producing enterococci","volume":"36","author":"Murray","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib6","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI111042","article-title":"Transferable beta\u2010lactamase. A new mechanism for in vitro penicillin resistance inStreptococcus faecalis","volume":"72","author":"Murray","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib7","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1128\/AAC.49.7.2954-2958.2005","article-title":"Mechanisms of resistance to imipenem and ampicillin inEnterococcus faecalis","volume":"49","author":"Ono","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","article-title":"Vancomycin\u2010resistant enterococcal infections","volume":"10","author":"Murray","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/13.1.1","article-title":"Enterococcal endocarditis: a comparison of prosthetic and native valve disease","volume":"13","author":"Rice","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-116-4-285","article-title":"Infections due to beta\u2010lactamase\u2010producing, high\u2010level gentamicin\u2010resistantEnterococcus faecalis","volume":"4","author":"Wells","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/JB.62.5.663-668.1951","article-title":"Further observations on the zone phenomenon in the bactericidal action of penicillin","volume":"62","author":"Eagle","year":"1951","journal-title":"J Bacteriol"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/14787210.6.5.637","article-title":"Emergence and management of drug\u2010resistant enterococcal infections","volume":"6","author":"Arias","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/313949","article-title":"Aminoglycoside resistance in enterococci","volume":"31","author":"Chow","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib14","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1172\/JCI106758","article-title":"Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C\u2010labeled streptomycin by enterococci","volume":"50","author":"Moellering","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JB.105.3.873-879.1971","article-title":"Mechanism of resistance to antibiotic synergism in enterococci","volume":"105","author":"Zimmermann","year":"1971","journal-title":"J Bacteriol"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/infdis\/147.4.751","article-title":"High\u2010level resistance to gentamicin in clinical isolates of enterococci","volume":"147","author":"Mederski\u2010Samoraj","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/oxfordjournals.jac.a020872","article-title":"In\u2010vitro activity of the combination of ampicillin and arbekacin against high\u2010level gentamicin\u2010resistant enterococci","volume":"42","author":"Kariyama","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib18","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/AAC.39.9.1984","article-title":"Synergistic effect of amoxicillin and cefotaxime againstEnterococcus faecalis","volume":"39","author":"Mainardi","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","article-title":"Brief communication: treatment ofEnterococcus faecalis endocarditis with ampicillin plus ceftriaxone","volume":"8","author":"Gavalda","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3109\/00365549709035908","article-title":"High\u2010level aminoglycoside\u2010resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin","volume":"29","author":"Antony","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/infdis\/173.4.909","article-title":"Effective treatment of multidrug\u2010resistant enterococcal experimental endocarditis with combinations of cell wall\u2010active agents","volume":"173","author":"Brandt","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib22","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19046-en","article-title":"Emergence and spread of vancomycin resistance among enterococci in Europe","volume":"13","author":"Werner","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin\u2010resistantStaphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1592\/phco.28.4.458","article-title":"Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram\u2010positive infections","volume":"28","author":"Leonard","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib25","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1086\/648438","article-title":"Telavancin: a novel lipoglycopeptide","volume":"49","author":"Saravolatz","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7164\/antibiotics.49.575","article-title":"Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity","volume":"49","author":"Cooper","year":"1996","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib27","unstructured":"Wasilewski MM, Disch PP, McGill JM, Harris HW, O\u2019Riordan W, Zeckel ML. Equivalence of shorter course therapy with oritavancin vs vancomycin\/cephalexin in complicated skin\/skin structure infections. 2001. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL, USA. Paper 16\u201319."},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib28","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jmb.2009.06.064","article-title":"Vancomycin and oritavancin have different modes of action inEnterococcus faecium","volume":"5","author":"Patti","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/AAC.00766-08","article-title":"Oritavancin kills stationary\u2010phase and biofilmStaphylococcus aureus cells in vitro","volume":"53","author":"Belley","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib30","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/AAC.44.11.3017-3021.2000","article-title":"Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin\u2010susceptible or \u2010resistantEnterococcus faecalis","volume":"44","author":"Lefort","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.43.1.115","article-title":"Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin\u2010resistantEnterococcus faecalis","volume":"43","author":"Saleh\u2010Mghir","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2007.05.180","article-title":"Daptomycin","volume":"55","author":"Enoch","year":"2007","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib33","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization inStaphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/AAC.45.2.454-459.2001","volume":"45","author":"Akins","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib35","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/AAC.47.5.1689-1693.2003","article-title":"Baseline study to determine in vitro activities of daptomycin against gram\u2010positive pathogens isolated in the United States in 2000\u20132001","volume":"47","author":"Critchley","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib36","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1128\/AAC.49.12.5166-5168.2005","article-title":"In vitro synergy of daptomycin plus rifampin againstEnterococcus faecium resistant to both linezolid and vancomycin","volume":"49","author":"Pankey","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.33.4.470","article-title":"In vitro synergism between daptomycin and fosfomycin againstEnterococcus faecalis isolates with high\u2010level gentamicin resistance","volume":"33","author":"Rice","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1179\/joc.2005.17.6.614","article-title":"Evaluation of in vitro interaction of daptomycin with gentamicin or beta\u2010lactam antibiotics againstStaphylococcus aureus and Enterococci by FIC index and timed\u2010kill curves","volume":"17","author":"Snydman","year":"2005","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1086\/522656","article-title":"Failure of daptomycin monotherapy for endocarditis caused by anEnterococcus faecium strain with vancomycin\u2010resistant and vancomycin\u2010susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster","volume":"10","author":"Arias","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib40","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/444459","article-title":"Endocarditis due to vancomycin\u2010resistant enterococci: case report and review of the literature","volume":"8","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jhm.236","article-title":"Linezolid\u2010 and vancomycin\u2010resistantEnterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin","volume":"2","author":"Jenkins","year":"2007","journal-title":"J Hosp Med"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib42","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1345\/aph.1M324","article-title":"Multidrug\u2010resistantEnterococcus faecium endocarditis treated with combination tigecycline and high\u2010dose daptomycin","volume":"43","author":"Schutt","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0b013e3181c806d8","article-title":"Multidrug\u2010resistantEnterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intravecular daptomycin and tigecycline","author":"Jaspan","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib44","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1365-2958.2007.05744.x","article-title":"Acquisition of a natural resistance gene renders a clinical strain of methicillin\u2010resistantStaphylococcus aureus resistant to the synthetic antibiotic linezolid","volume":"64","author":"Toh","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1128\/JCM.01886-07","article-title":"Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase","volume":"46","author":"Arias","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/345744","article-title":"Linezolid for the treatment of multidrug\u2010resistant, gram\u2010positive infections: experience from a compassionate\u2010use program","volume":"2","author":"Birmingham","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib47","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkl219","article-title":"Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence","volume":"58","author":"Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib49","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1086\/375877","article-title":"Failure of linezolid treatment for enterococcal endocarditis","volume":"3","author":"Zimmer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1128\/JCM.02188-06","article-title":"Vancomycin\u2010resistantEnterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors","volume":"45","author":"Tsigrelis","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib51","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/00365540802087209","article-title":"Short\u2010term success, but long\u2010term treatment failure with linezolid for enterococcal endocarditis","volume":"40","author":"Berdal","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/SMJ.0b013e31816c01ef","article-title":"Vancomycin\u2010resistantEnterococcus faecium meningitis successfully treated with linezolid","volume":"101","author":"Mizell","year":"2008","journal-title":"South Med J"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1368-5031.2006.00706.x","article-title":"Short course of linezolid treatment for vancomycin\u2010resistantEnterococcus faecium meningitis","volume":"60","author":"Tsai","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/106002809502901013","article-title":"Quinupristin\/dalfopristin (RP 59500): a new streptogramin antibiotic","volume":"29","author":"Chant","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-0691.2007.01933.x","article-title":"New antimicrobial agents for the treatment of Gram\u2010positive bacterial infections","volume":"14","author":"Aksoy","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"suppl A","key":"10.1111\/j.1469-0691.2010.03214.x_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/39.suppl_1.7","article-title":"Inhibition of protein synthesis by streptogramins and related antibiotics","volume":"39","author":"Cocito","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib57","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2165\/00003495-199652030-00006","article-title":"Quinupristin\u2010dalfopristin","volume":"52","author":"Bryson","year":"1996","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1128\/AAC.49.1.32-39.2005","article-title":"Differences in theEnterococcus faecalis lsa locus that influence susceptibility to quinupristin\u2010dalfopristin and clindamycin","volume":"49","author":"Singh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib59","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1128\/AAC.46.6.1845-1850.2002","article-title":"AnEnterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin\u2010dalfopristin","volume":"46","author":"Singh","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib60","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1086\/323899","article-title":"Treatment of vancomycin\u2010resistantEnterococcus faecium infections with quinupristin\/dalfopristin","volume":"11","author":"Linden","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib61","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1086\/517755","article-title":"Treatment of endocarditis due to vancomycin\u2010resistantEnterococcus faecium with quinupristin\/dalfopristin, doxycycline, and rifampin: a synergistic drug combination","volume":"27","author":"Matsumura","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib62","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1345\/aph.1D377","article-title":"Treatment of vancomycin\u2010resistant enterococcus with quinupristin\/dalfopristin and high\u2010dose ampicillin","volume":"38","author":"Bethea","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib63","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1345\/aph.1H543","article-title":"Tigecycline: a novel broad\u2010spectrum antimicrobial","volume":"41","author":"Slover","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"suppl 5","key":"10.1111\/j.1469-0691.2010.03214.x_bib64","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1086\/431672","article-title":"Tigecycline: a new glycylcycline for treatment of serious infections","volume":"41","author":"Noskin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib65","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/jac\/dkn065","article-title":"Tigecycline\u2010resistantEnterococcus faecalis strain isolated from a German intensive care unit patient","volume":"61","author":"Werner","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib66","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/431675","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin\u2010structure infections: results of 2 double\u2010blind phase 3 comparison studies with vancomycin\u2010aztreonam","volume":"5","author":"Ellis\u2010Grosse","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib67","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1086\/431676","article-title":"The efficacy and safety of tigecycline for the treatment of complicated intra\u2010abdominal infections: analysis of pooled clinical trial data","volume":"5","author":"Babinchak","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib68","doi-asserted-by":"crossref","first-page":"8e1","DOI":"10.1016\/j.ijantimicag.2008.11.006","article-title":"Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies","volume":"34","author":"Entenza","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkl441","article-title":"Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report","volume":"59","author":"Peleg","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib71","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3201\/eid0809.010435","article-title":"First characterization of a cluster of VanA\u2010type glycopeptide\u2010resistantEnterococcus faecium, Colombia","volume":"8","author":"Panesso","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/clinids\/20.5.1137","article-title":"Chloramphenicol for the treatment of vancomycin\u2010resistant enterococcal infections","volume":"20","author":"Norris","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib73","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/515002","article-title":"The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin\u2010resistant enterococcus","volume":"27","author":"Lautenbach","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1469-0691.2001.00189.x","article-title":"Chloramphenicol treatment for vancomycin\u2010resistantEnterococcus faecium bacteremia","volume":"7","author":"Ricaurte","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib75","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1086\/340527","article-title":"Prosthetic valve endocarditis due to vancomycin\u2010resistantEnterococcus faecium: treatment with chloramphenicol plus minocycline","volume":"34","author":"Safdar","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib76","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jac\/dkm542","article-title":"Selection of linezolid\u2010resistantEnterococcus faecium in an in vitro dynamic model: protective effect of doxycycline","volume":"61","author":"Zinner","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jinf.2007.11.003","article-title":"Chronic bacterial prostatitis and relapsingEnterococcus faecalis bacteraemia successfully treated with moxifloxacin","volume":"56","author":"Van Nieuwkoop","year":"2008","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib78","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/jac\/40.5.737","article-title":"Combination of co\u2010trimoxazole and ciprofloxacin as therapy of a patient with infective endocarditis caused by an enterococcus highly resistant to gentamicin","volume":"40","author":"Rambaldi","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/36.1.253","article-title":"Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug\u2010resistantEnterococcus faecium","volume":"36","author":"Landman","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dkm237","article-title":"Evaluation of ceftobiprole medocaril againstEnterococcus faecalis in a mouse peritonitis model","volume":"60","author":"Arias","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib81","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/AAC.00131-07","article-title":"Time\u2010kill and synergism studies of ceftobiprole againstEnterococcus faecalis, including beta\u2010lactamase\u2010producing and vancomycin\u2010resistant isolates","volume":"51","author":"Arias","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib82","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/AAC.00984-09","volume":"53","author":"Jacqueline","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03214.x_bib70","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1086\/320542","article-title":"Clinical and epidemiological features ofEnterococcus casseliflavus\/flavescens andEnterococcus gallinarum bacteremia: a report of 20 cases","volume":"11","author":"Reid","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1461689X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1461689X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T20:40:59Z","timestamp":1637354459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1461689X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1198743X1461689X"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03214.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}